CPB2 antibody
Quick Overview for CPB2 antibody (ABIN7536744)
Target
See all CPB2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- TAFI - Thrombin Activatable Fibrinolysis Inhibitor Polyclonal Antibody - Affinity Purified
-
Specificity
- Human thrombin-activatable fibrinolysis inhibitor, TAFI
-
Purification
- Antigen-specific affinity purification
-
Immunogen
- Human TAFI purified from plasma
-
Isotype
- IgG
-
-
-
-
Application Notes
- Immunoblot 0.5-5 μg/mL, ELISA capture 10 μg/mL
-
Comment
-
Affinity-purified IgG are antibodies further purified using immobilized antigen. Affinity-purification is an enrichment process in which whole IgG is passed over a resin to which antigen has been covalently attached. Non-reactive antibodies are washed away and specific antibodies are eluted under conditions that disrupt the antigen-antibody interaction. The result is a very high-purity product with a substantially higher titre than whole IgG. This level of product is intended for applications such as immunoblotting, immunostaining of cells and several types of immunoassays where the higher signal-to-noise ratio achieved with this enriched product is required.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Reconstitution
- Allow product to warm to room temperature and gently mix before use
-
Concentration
- 2 mg/mL
-
Buffer
- 10 mM HEPES, pH 7.4, 150 mM NaC, 50 % (v/v) glycerol
-
Storage
- -20 °C
-
Storage Comment
- Store between -10°C and -20°C
-
-
- CPB2 (Carboxypeptidase B2 (Plasma) (CPB2))
-
Alternative Name
- TAFI
-
Pathways
- Regulation of Actin Filament Polymerization, Carbohydrate Homeostasis
Target
-